Culture Biosciences

Surveying great inventors and businesses

Axial: https://linktr.ee/axialxyz

Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at   info@axialvc.com

Culture Biosciences is the market leader for biomanufacturing in the cloud. Founded by Will Patrick and Matt Ball, college roommates at Duke who also worked at Google X together, the company is integrating hardware and software to scale up fermentation.

We need 10Ms of liters of fermentation capacity to meet growing demand from biopharma & alternative protein products. Depending on the latter’s adoption, capacity may need to 10x to 100x to go from 0.1 million MT capacity currently to >10M MT.

With Pivot Bio, Geltor, EVERY™, among others as customers, Culture allows everything from strain screening to media selection with line-of-sight to own everything from process development to upstream fermentation at scale and downstream processing.

They can analyze fermentation data just like quant funds analyze stock charts to hopefully go from 5L bioreactors to 500K liters. Culture takes a unique view to treat each bioreactor as a singular unit similar to fault tolerant servers to stack and increase capacity over time.

Find current job openings for Culture
https://www.culturebiosciences.com/careers